Press Enter to search · Esc to close
Premium energy-based devices promise to roll back skin aging. A new systematic review asks whether they truly act on the biology of senescence — or just polish the surface.
Two 2025 studies converge on a striking thesis — that clearing senescent cells, with drugs or even intermittent pressure, may halt age-related bone loss in mice. Here's what the preclinical signal actually says.
Three converging 2025 reviews sketch an integrated picture of why tissues deteriorate—and where senolytics, NAD+ modulators, and lysosome-restoring therapies might one day intervene.
A 1,416-patient analysis suggests a curated senescence gene signature tracks with survival in multiple myeloma — an early but credible sign that geroscience biomarkers may sharpen oncology prognosis.